Post-approval studies (Phase 4)Study completedNCT02328963
What this trial is testing
Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A
Who this might be right for
Transplantation InfectionCytomegalovirus Infection
University Hospital, Bordeaux 186